Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Costa

Showing results (291-300 of 311) with videos related to

Pageof 32
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 15, 2020
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesionsMarco Zimarino, Dominick J Angiolillo, George Dangas, et al.
Inflammatory Bowel Diseases|January 17, 2017
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab BiosimilarGionata Fiorino, Natalia Manetti, Alessandro Armuzzi, et al.
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Open Heart|August 26, 2025
Adverse cardiovascular events in coronary Plaques not undeRgoing pErcutaneous coronary intervention evaluateD with optIcal Coherence Tomography. The PREDICT-AI risk modelFrancesco Bruno, Maddalena Immobile Molaro, Michela Sperti, et al.
Inflammatory Bowel Diseases|August 24, 2018
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across ItalyAlessandro Armuzzi, Gionata Fiorino, Angela Variola, et al.
International Journal of Cardiology|September 27, 2025
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical backgroundErnest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, et al.
Journal of the American College of Cardiology|September 2, 2025
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized TrialRaffaele Piccolo, Paolo Calabrò, Greta Carrara, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 22, 2020
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcationsGuglielmo Gallone, Fabrizio D'Ascenzo, Federico Conrotto, et al.
Journal of Clinical Medicine|May 28, 2022
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 PandemicRoberto Licordari, Alessandro Sticchi, Filippo Mancuso, et al.
Minerva Cardiology and Angiology|October 28, 2022
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortalityAlessandro Sticchi, Francesco Costa, Saverio Muscoli, et al.
Pageof 32

Showing results (291-300 of 311) with videos related to

Sort By:
Pageof 32
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 15, 2020
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesionsMarco Zimarino, Dominick J Angiolillo, George Dangas, et al.
Inflammatory Bowel Diseases|January 17, 2017
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab BiosimilarGionata Fiorino, Natalia Manetti, Alessandro Armuzzi, et al.
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Open Heart|August 26, 2025
Adverse cardiovascular events in coronary Plaques not undeRgoing pErcutaneous coronary intervention evaluateD with optIcal Coherence Tomography. The PREDICT-AI risk modelFrancesco Bruno, Maddalena Immobile Molaro, Michela Sperti, et al.
Inflammatory Bowel Diseases|August 24, 2018
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across ItalyAlessandro Armuzzi, Gionata Fiorino, Angela Variola, et al.
International Journal of Cardiology|September 27, 2025
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical backgroundErnest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, et al.
Journal of the American College of Cardiology|September 2, 2025
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized TrialRaffaele Piccolo, Paolo Calabrò, Greta Carrara, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 22, 2020
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcationsGuglielmo Gallone, Fabrizio D'Ascenzo, Federico Conrotto, et al.
Journal of Clinical Medicine|May 28, 2022
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 PandemicRoberto Licordari, Alessandro Sticchi, Filippo Mancuso, et al.
Minerva Cardiology and Angiology|October 28, 2022
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortalityAlessandro Sticchi, Francesco Costa, Saverio Muscoli, et al.
Pageof 32